15+ years bridging laboratory science and real-world impact. End-to-end support — from prototype to FDA Class I, regulatory clearance, and global product launch.
Lab-to-market wearables. Concept definition, prototyping, system architecture, and technical de-risking through validated MVP.
Design for manufacture, factory identification, supply-chain set-up, and production-scale transition across UK, EU, and South Asia.
FDA, CE, ISO 13485 strategy. Risk classification, technical documentation, and audit readiness for medical wearables.
Trial design, evidence frameworks, and translational research support. From in-vitro through human factors to clinical study.
Keynotes, executive panels, and university masterclasses on wearable technology, biomaterials, and MedTech commercialisation.
Translational research mentoring through Imperial — Moratuwa, Swansea, and Queen Mary academic collaborations.
Patent filing, portfolio building, and freedom-to-operate analysis. 3 granted patents across compression and biosensor wearables.
Independent technology and IP evaluation for VCs, investors, and acquirers considering MedTech / HealthTech deals.
Angelo stands out as a dedicated and innovative professional in biomedical engineering. His deep knowledge in bone biomechanics and his ability to lead and inspire teams towards innovative solutions is remarkable — his contributions to our joint projects have been invaluable.
I had the privilege of working with Dr. Angelo as my co-supervisor during my PhD. His expertise in synchrotron X-ray imaging and mechanical testing was instrumental in guiding our osteoporotic bone research. He explained complex concepts in an accessible manner, and his insights were invaluable in shaping both our research and my academic growth.
Dr. Angelo is an exemplary leader in biomedical engineering, specializing in biomaterials and wearable tech. His innovative approach and profound expertise in strategic operations significantly enhance any project he undertakes. His leadership and vision consistently drive success.
Having worked under Angelo for over four years, I see him as a dedicated and committed professional with strong critical thinking and creative problem-solving skills. His knowledge in biomedical engineering is extensive, and his exceptional leadership helped build the Health and Wellness pillar of MAS Holdings. He can be an asset to any company.
Angelo's expertise in biomaterials and wearable technology, coupled with his leadership at MAS Innovations, makes him an exceptional figure in his field. His multidisciplinary skills and over a decade of leadership experience make him an invaluable asset to any team.
A proven track record turning elite biomedical research into commercialised products — from $1.2M+ Spryng launch revenue and ISPO 2020 Best Start-up award, to clinical-grade elderly-care wearables. Currently leading DSTL-funded research on blast-resistant protective wearables at Swansea University, while serving as CSIO at VitalProbe Inc., CTO at B-CAN Solutions, and Senior Consultant at Milbotix.
Holds a PhD and MEng in Biomedical Engineering from Queen Mary University of London, and is Chartered Engineer with both IMechE (UK) and Engineers Australia. Winner of the Best Doctoral Thesis in Biomechanics, European Society of Biomechanics Congress 2013.
A decade of translating biomedical research into market-ready wearables, clinical devices, and precision instruments — from FDA-cleared compression therapy to AI-enabled elderly-care platforms.
The world’s most advanced wireless pneumatic compression wrap for athletic recovery. Raised $1.2M+ on Kickstarter / Indiegogo, launched at NYC Marathon and CES 2019, now sold globally.
Clinical adaptation of the patented compression platform for upper-arm and forearm lymphoedema management. Wellness-grade aesthetic, hospital-grade therapy.
AI-enabled wearable socks for continuous gait analysis, fall-risk monitoring, and calmness assessment in dementia and elderly care. Clinical studies with UWE Bristol.
Premium consumer wellness wearable. Ergonomic anatomical form, invisible sensor integration, edge-lit aesthetic. Currently in development — product details under NDA.
Clinical-grade chest-worn wearable integrating ECG, fall detection, and sleep analytics. Leading IP development, R&D roadmap, and clinical validation as Chief Science & Innovation Officer.
Self-charging, washable smart bra for early breast cancer detection. Leading feasibility assessments, investor engagement, and market-entry planning across UK, EU, and South Asia as CTO.
Architecturally-engineered biopolymer scaffolds with hierarchical porous structure for guided bone regeneration. Imperial College — Moratuwa collaboration on 3D-printed hybrid scaffolds.
Engineered ligament constructs combining biopolymer scaffolds with cell seeding for orthopaedic repair. PhD-era research on hierarchical fibre architecture mimicking natural collagen.
Custom-built rig for simulating human limb pressurisation under wearable garments. Featured in the BSSM 2025 talk at Imperial College London.
Precision research-grade rig for micron-scale mechanical testing of bone samples. Used at Diamond Light Source synchrotron beamlines for in-situ nanomechanical imaging.
A decade of inventing at the intersection of smart textiles, soft actuation, and embedded sensing — translated into clinically validated, commercially launched wearable platforms.
A patented seamless flat-bed knitted structure housing 3 independent pneumatic chambers in a single textile layer. Enables programmable zone-targeted compression without bonded inserts or wasted material — a direct precursor to soft robotic cell fabrication in wearable form.
A 135 × 8 cm elastic knitted textile with an embedded zig-zag resistive heating wire, integrated temperature sensors, and detachable Bluetooth smart control module. Delivers controlled therapeutic heat to knee, elbow, wrist, and ankle — validated in a 26-patient clinical study supervised by a Consultant Orthopaedic Surgeon.
A wearable garment system that integrates multi-modal biosensors within a textile substrate to enable continuous, non-invasive physiological monitoring during daily wear. The architecture embeds sensing elements — including impedance-based biomarker sensors — directly within the garment construction, with embedded data acquisition and wireless transmission.
Designed to bridge the gap between clinical-grade diagnostic accuracy and everyday wearability, this technology forms the foundational IP platform for downstream applications in breast cancer early detection (BCan), elderly monitoring (VitalProbe), and lymphoedema management.
morph., the London soft robotics startup launched in June 2026, describes its mission as ‘embedding sensing and adaptive control directly into reconfigurable deformable materials.’ These three patents represent exactly that — built, validated, and commercialised years before the term ‘physical AI’ entered the mainstream. The knitted air bladder system is a manufacturable, clinically validated precedent for soft robotic cells designed for human-body interaction.
From synchrotron beamlines and 3D-printed bioactive scaffolds to international keynotes and HealthTech conferences — a glimpse into the work that bridges laboratory science and real-world impact.
Whether you're looking to collaborate on research, explore consulting opportunities, book a speaking engagement, or simply connect — I'd love to hear from you.